Nutraveris
Tuesday, February 26, 2019
Category : NEWS, REGULATORY | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

EFSA

EFSA has published in January 2019 :

A Guidance on Communication of Uncertainty in Scientific Assessments: this document provides guidance for communicators on how to communicate the various expressions of uncertainty. The guidance was formulated using evidence from the scientific literature, grey literature and two EFSA research studies, or based on judgement and reasoning where evidence was incomplete or missing.

A Report on EFSA’s activities on emerging risks in 2017: the following subjects are cited as potential emerging issues: Risk associated with the use of black cohosh in food supplements and tea, Use of nanoemulsions in the food sector, Potential risk related to high level/content of nutrients in fortified foods.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Thursday, February 21, 2019
Category : NEWS, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This meta-analysis was performed with 17 randomized clinical trials and evaluated the effects of omega-3 supplementation among 3363 patients in the management of dry eye disease.

omega-3 supplementation

Compared with placebo, omega-3 fatty acid supplementation decreased dry eye symptoms (p < 0.001) and corneal fluorescein staining (p = 0.032), whereas it increased the breakup time (p < 0.001) and Schirmer test values (used to test the amount of tears) (p < 0.001). No evidence of publication bias was observed, and sensitivity analyses indicated the robustness of results obtained. Meta-regression analysis showed a higher improvement of dry eye symptoms and breakup time in studies conducted in India.

 

In conclusion, this meta-analysis provides evidence that omega-3 fatty acid supplementation significantly improves dry eye symptoms and signs in patients with dry eye disease. 

 

Giannaccare G, Pellegrini M, Sebastiani S, Bernabei F, Roda M, Taroni L, Versura P, Campos EC.Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials. Cornea. 2019 Jan 29.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, February 19, 2019
Category : NEWS, INGREDIENTS, REGULATORY | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

In January 2019, the French Minister of Economy and Finance reaffirmed his will to ban titanium dioxide (E171), in accordance with the Government’s position and the provisions voted by Parliament in Article 53 of the French law on food published on 1 November 2018.

titanium dioxide

In order to gather the necessary legal conditions for this ban, he therefore asked ANSES (French scientific evaluation agency) to accelerate its work on nanoparticles for the TiO2 by 15 April, in order to update its previous evaluation based on new available studies.

On the basis of this ANSES report, the French Government wishes to publish, where appropriate, an order as early as April 2019 on a suspension of the placing on the market of foods containing titanium dioxide.

Concretely, for the moment you can continue to put on the market in France your products (foodstuffs including food supplements) which currently contain titanium dioxide, however we recommend to study as soon as possible reformulation solutions to change this additive, in order to be ready in the event that this ban in France would be confirmed by the publication of an order in the French Official Journal.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

 

Thursday, February 14, 2019
Category : NEWS, INGREDIENTS, CLINICAL EVIDENCE | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

Vitamin C is a strong antioxidant. The authors of this study wished to determine whether this antioxidant capacity can help to prevent exercise-induced muscle damage. 19 healthy women have been recruited for this randomized, double-blinded and placebo-controlled trial which used a crossover design including a 1-week washout period.

They performed 30 min moderate intensity cycling after ingesting 1 g vitamin C or placebo.

Vitamin C

Vitamin C prevented the increases in plasma albumin and total protein levels, and the reduction in glucose observed after placebo (p = 0.001). Superoxide dismutase was increased after placebo but not after vitamin C (p = 0.002), whereas malondialdehyde decreased only after the vitamin C supplementation (p < 0.05). Slight muscle damage have been noted in both groups after exercise, without differences between groups.

 

Therefore, vitamin C possesses antioxidant effects during exercise, but does not prevent muscle damage.

 

Yimcharoen M, Kittikunnathum S, Suknikorn C, Nak-On W, Yeethong P, Anthony TG, Bunpo P. Effects of ascorbic acid supplementation on oxidative stress markers in healthy women following a single bout of exercise. J Int Soc Sports Nutr. 2019 Jan 21;16(1):2.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, February 12, 2019
Category : NEWS, INGREDIENTS, REGULATORY | Author : experts | Comment : No Comments
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10 years by more than 500 industry leaders informs you:

The Novel food Catalogue entries for Cannabis sativa L. and Cannabidiol / Cannabinoids have been updated in January 2019 and now indicate that :

  • “Some products derived from the Cannabis sativa plant or plant parts such as seeds, seed oil, hemp seed flour, defatted hemp seed have a history of consumption in the EU and therefore, are not novel. Other specific national legislation may restrict the placing on the market of this product as a food or food ingredient in some Member States.” Only ingredients derived from hemp seed are now cited as having a history of consumption in the EU.
  • “Extracts of Cannabis sativa L. and derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated. This applies to both the extracts themselves and any products to which they are added as an ingredient (such as hemp seed oil). This also applies to extracts of other plants containing cannabinoids. Synthetically obtained cannabinoids are considered as novel.”

This modification clarifies that the European Authorities consider that it is forbidden to market food or food supplements containing cannabidiol in all the European Union (considered as novel according to Regulation (EU) 2015/2283). For information a novel food application for trans-cannabidiol (for a use in food supplements) is under assessment by EFSA and the opinion is expected to be published in March 2019.

 

Cannabis sativa

 

For example in UK where some cannabidiol products were already marketed because of an unclear legal context, it is now indicated on the website of the FSA: There has been a recent change to the EU Novel Food Catalogue which affects some cannabidiol (CBD) products. Food businesses have not been able to show there was a significant history of consumption of these products in food and food supplements prior to May 1997 in the EU. The FSA are considering the way forward in light of this clarification at EU level (meeting with relevant industry representative bodies, local authorities and other stakeholders to clarify how to achieve compliance in the marketplace in a proportionate manner).

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87